Physician

Yi Feng, MD

According to 2025 Medicare claims, Yi Feng, MD (NPI: 1639179229) practices medical oncology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is TENNESSEE CANCER SPECIALISTS PLLC (NPI: 1841228871; TIN: 200677400) and primary practice location at 37932-3366.

Feng's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,028 traditional Medicare patients, billed 490,822 HCPCS/CPT codes, and received $7,422,035 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,136 prescription claims across 399 beneficiaries totaling $5,933,279 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 36 claims. Open Payments data shows 217 records totaling $7,107. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,107,329 to $7,422,035. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,203,488 to $5,933,279. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.7M$7.4M2015 Medicare payment: $2,107,329 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,618,849 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,185,988 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,157,750 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,651,401 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,511,918 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,600,466 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,882,327 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $7,081,595 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $7,422,035 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015529235,319$2,107,329
2016548246,829$2,618,849
2017563274,020$3,185,988
2018758304,385$4,157,750
2019735394,051$5,651,401
2020724372,871$5,511,918
2021792452,595$5,600,466
20221,062472,392$5,882,327
20231,046487,077$7,081,595
20241,028490,822$7,422,035

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.2M$6.4M2015 Drug cost: $1,203,488 (USD; Tot_Drug_Cst)2016 Drug cost: $1,581,464 (USD; Tot_Drug_Cst)2017 Drug cost: $2,100,673 (USD; Tot_Drug_Cst)2018 Drug cost: $2,346,688 (USD; Tot_Drug_Cst)2019 Drug cost: $3,469,424 (USD; Tot_Drug_Cst)2020 Drug cost: $4,372,928 (USD; Tot_Drug_Cst)2021 Drug cost: $4,151,116 (USD; Tot_Drug_Cst)2022 Drug cost: $4,567,045 (USD; Tot_Drug_Cst)2023 Drug cost: $6,416,756 (USD; Tot_Drug_Cst)2024 Drug cost: $5,933,279 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151981,397$1,203,488
20162271,565$1,581,464
20172051,585$2,100,673
20182331,485$2,346,688
20192701,833$3,469,424
20202681,619$4,372,928
20213171,738$4,151,116
20223561,794$4,567,045
20233892,197$6,416,756
20243992,136$5,933,279

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.7K$5.4K2015 Medicare payment: $5,360 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,751 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,983 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,686 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,106 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,266 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,777 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,499 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,347 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,952 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R86$5,360
2016N/R50$1,751
2017N/R70$2,983
2018N/R61$2,686
2019N/R62$3,106
2020N/R50$2,266
2021N/R56$2,777
2022N/R62$2,499
2023N/R45$2,347
2024N/R36$1,952

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4511,152$87
80053Blood test, comprehensive group of blood chemicals8852,415$10
36415Insertion of needle into vein for collection of blood sample8852,604$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count9003,070$8
83540Iron level447843$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide451,141$842,966
IbrancePalbociclib471,302$658,591
JakafiRuxolitinib Phosphate351,050$604,296
LenalidomideLenalidomide561,167$557,927
RevlimidLenalidomide32707$413,644

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R23$1,739
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R13$213

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.217$7,107Boehringer Ingelheim Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Yi Feng, MD?

Tedicare shows public-source Medicare data for Yi Feng, MD (NPI 1639179229), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yi Feng, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yi Feng, MD?

Yi Feng, MD is linked to TENNESSEE CANCER SPECIALISTS PLLC (billing NPI 1841228871) in the available physician profile data.

Does Yi Feng, MD have Open Payments data?

Yi Feng, MD has 217 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.